Du måste aktivera javascript för att sverigesradio.se ska fungera korrekt och för att kunna lyssna på ljud. Har du problem med vår sajt så finns hjälp på http://kundo.se/org/sverigesradio/

Anti-Smoking Vaccine Trialled in Sweden

Published måndag 28 april 2008 kl 13.47

A new vaccine against nicotine dependency is to go on wide scale trial for the first time.

Swedish newspaper, Svenska Dagbladet, reports that the vaccine developed by the company Independent Pharmaceutica together with researchers at the Karolinska Institute is to be tested on people in Scandinavia to help them to try and stop smoking. Researchers are currently searching for 400 smokers who want to kick the habit.

The vaccine works on the principle that the body’s immune defences will develop anti-bodies against nicotine that prevent the drug reaching the brain and therefore stop the smoker from getting the nicotine rush they crave.

It is hoped that the vaccine will create long lasting anti-bodies in the patient’s immune system and may be used as a conventional aid to helping people to quit smoking in the future.

Our journalism is based on credibility and impartiality. Swedish Radio is independent and not affiliated to any political, religious, financial, public or private interests.
Har du frågor eller förslag gällande våra webbtjänster?

Kontakta gärna Sveriges Radios supportforum där vi besvarar dina frågor vardagar kl. 9-17.

Du hittar dina sparade avsnitt i menyn under "Min lista".